Developer docs
API playgroundTry for free, no card

Search company profiles

SigmaGraft

Full company profile

uuid000ebxf

Namestring
SigmaGraft
Legal namestring
SigmaGraft Biomaterials, Inc.
Websiteurl
sigmagraft.com
Company typeenum
Private
Founded yearint
2010
Descriptiontext

SigmaGraft Biomaterials, Inc. is a privately held U.S. manufacturer of dental and orthopedic biomaterials, founded in 2010 and operating from Brea, California (corporate headquarters at 450 Apollo St Ste B) and Fullerton, California (manufacturing facility at 575 Sally Place). The company designs, produces, and distributes bone graft substitutes, resorbable collagen membranes, synthetic bioceramics, wound dressings, and sutures used in guided bone regeneration (GBR), guided tissue regeneration (GTR), dental implantology, periodontal surgery, spinal fusion, and orthopedic trauma. Its portfolio spans allograft (SigmaOss), xenograft (InterOss), bone-collagen composites (InterOss Collagen), biphasic and tricalcium phosphate ceramics (BoneSigma BCP/TCP), resorbable collagen membranes (InterCollagen Guide), DBM products (AlloGen), active bone graft substitutes for spine (ExcellBone Active), sports medicine/trauma grafts (MaximOss), and wound dressings (SigmaPlug, SigmaTape).

Underlying technology centers on biomaterial scaffolds with controlled porous architecture (e.g., InterOss macropores of 40–60 μm and micro-channels ≤1.5 μm) designed to mimic natural trabecular bone and support osteoconduction. Manufacturing is vertically integrated in ISO Class 7 cleanroom environments under ISO 13485 certification, enabling both proprietary product lines and contract manufacturing services for other medical device companies.

SigmaGraft monetizes through one-time product sales across three channels: a direct e-commerce storefront (shop.sigmagraft.com), a dedicated customer service sales team, and a global distribution network serving more than 60 countries. The company also offers contract manufacturing for third-party dental, spine, and orthopedic device companies. Customer education and clinical faculty relationships (e.g., SigmaGraft Bone & Tissue Regeneration CE course, VISTA Institute programs) function as a marketing and brand-building layer rather than a direct revenue stream. Pricing is quote-based and not publicly disclosed; no revenue figures, funding rounds, or ownership disclosures are available in the source data, indicating an independent, likely founder-controlled private company.

Short descriptiontext

SigmaGraft Biomaterials is a privately held U.S. manufacturer of dental and orthopedic biomaterials — bone grafts, resorbable membranes, synthetic bioceramics, and wound dressings — sold in more than 60 countries to clinicians through distribution, e-commerce, and contract manufacturing.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersFullerton, United States
HQ citystring
Fullerton
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
bone graft substitutes, dental biomaterials, orthopedic regenerative products, resorbable collagen membranes, synthetic bioceramics
Industry5 codes
1Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM)
CodeHLAHAEAGPrimaryYes
2Cartilage, Bone & Musculoskeletal Regeneration
CodeHLAAAGAHPrimaryNo
3Tissue-Engineered Constructs & Scaffolds (natural/synthetic biomaterials)
CodeHLAAAGABPrimaryNo
4Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts)
CodeHLAHALAEPrimaryNo
5Implant Prosthetics & Abutment Fabrication
CodeHLABAJACPrimaryNo
NAICS code4 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Dental Equipment and Supplies Manufacturing339114
  • Biological Product (except Diagnostic) Manufacturing325414
  • Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers42345
SIC code3 codes
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Biological Products, (No Disgnostic Substances)2836
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
Product category
Medical Device Biomaterials
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Biomaterial Products
TypeOne Time License
Description

Sale of bone graft substitutes, collagen membranes, wound dressings, and related medical devices for dental and orthopedic applications. Products are sold directly through e-commerce and distribution network.

sigmagraft.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1Medical device biomaterial products - pricing available upon request
ModelOtherBilling cadencePay-as-you-go
Notes

Quote-based / Not publicly disclosed - products sold to dental and orthopedic professionals through direct sales and distribution network

sigmagraft.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 9 records shown
1InterOss
Description

Anorganic cancellous bone graft granules derived from bovine source, featuring naturally interconnected porous architecture for osteoconductive scaffold in guided bone regeneration.

sigmagraft.com
+8 more records
Core offering1 text field

SigmaGraft manufactures and sells biomaterial products for bone and tissue regeneration, including allograft and xenograft bone substitutes, bone-collagen composites, synthetic biphasic and tricalcium phosphate bioceramics, resorbable collagen membranes, wound dressings, and surgical sutures. These products are used by dental professionals and orthopedic surgeons for guided bone regeneration, ridge preservation, dental implant placement, sinus augmentation, periodontal defect treatment, spinal fusion, trauma surgery, and sports medicine. The company also offers contract manufacturing services to other medical device companies using its ISO Class 7 facilities.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Products registered and sold in more than 60 countries worldwide
Product overview1 text field

SigmaGraft Biomaterials is a manufacturer of biomaterials for dental and orthopedic surgeries specializing in bone and tissue regeneration products. The product portfolio includes allograft bone substitutes (SigmaOss™), xenograft bone grafts (InterOss®), bone-collagen composites, biphasic and tricalcium phosphate ceramics (BoneSigma™), resorbable collagen membranes (InterCollagen® Guide), wound dressings (SigmaPlug™, SigmaTape™), demineralized bone matrix (AlloGen™ DBM), and sutures. The company operates in dental (bone grafting, tissue regeneration, wound care) and orthopedic (spine, sports medicine/trauma) segments, selling products in over 60 countries worldwide.

Product and service1 record
1SigmaOss™
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
1Leading Universities (Research Collaborations)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

SigmaGraft has established close partnerships with several leading universities for research and development. These collaborations provide access to cutting-edge research and technology, allowing the company to work alongside leading minds in the biomaterials field. Research has been published in several renowned, prestigious journals.

sigmagraft.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

SigmaGraft partners with VISTA Institute for dental education programs. Joint program on Management of Implant Functional and Esthetic Complications scheduled for July 11-12, 2026 in Woodland Hills, CA, featuring multiple clinicians and offering 16 CE units.

Strategic tierMinorTypeGTM or Marketing Partner
Description

SigmaGraft Industry Forums at EAO Congress 2026 in Lisbon, Portugal featuring Dr. Hom-Lay Wang discussing advancements in bone regeneration and implant therapy.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Stryker's orthobiologics portfolio includes Vitoss synthetic bone graft, OP-1 putty, and various allograft products. Comparable as a broad incumbent selling bone graft substitutes into orthopedic, spine, and trauma channels overlapping with SigmaGraft's orthopedic segment.

TypeDirect peer
Description

Specialist manufacturer of synthetic bioactive glass and calcium phosphate bone graft substitutes (NovaBone IRM, NovaBone Morsels). Direct peer for SigmaGraft's BoneSigma BCP/TCP ceramic lines in dental and orthopedic bone regeneration.

TypeDirect peer
Description

The global leader in dental bone regeneration (Bio-Oss xenograft, Bio-Gide membrane). Direct peer with overlapping product portfolio in dental bone graft substitutes and resorbable collagen membranes serving periodontists, oral surgeons, and implantologists worldwide.

TypeDirect peer
Description

French specialist in synthetic bone graft substitutes (MBCP biphasic calcium phosphate). Direct peer for SigmaGraft's bioceramic bone substitutes with comparable technology positioning in dental and orthopedic bone regeneration.

TypeBroad incumbent
Description

Through its Spine & Biologics division, Medtronic offers Infuse (rhBMP-2), Grafton DBM, and Mastergraft synthetic bone grafts. Directly comparable in orthopedic spine and trauma bone graft substitutes where SigmaGraft's AlloGen DBM and BoneSigma TCP compete.

TypeDirect peer
Description

Dental implant company with a regeneration portfolio including MinerOss xenograft and allograft bone substitutes plus resorbable membranes. Direct peer in dental bone grafting and tissue regeneration products sold through the same implantology channel.

TypeEmerging player
Description

Specialist manufacturer of collagen-based medical devices including dental membranes and bone graft substitutes. Comparable as a focused player in the collagen/membrane niche where SigmaGraft's InterCollagen Guide competes.

TypeBroad incumbent
Description

Major orthopedic and dental medical device company offering RegenerOss bone graft substitutes and dental implant solutions. Comparable because it sells allograft, xenograft, and synthetic bone grafts into the same dental and orthopedic surgical call points.

TypeBroad incumbent
Description

Global dental equipment and consumables leader with bone graft substitute offerings (e.g., Symbios) and the largest installed base in dental practices. Comparable as a broad incumbent in the dental regenerative materials space.

TypeDirect peer
Description

US-based dental surgical supply company offering bone graft materials, membranes, and regenerative products to periodontists and oral surgeons. Comparable mid-size peer with overlapping dental bone graft and tissue regeneration catalog.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SigmaGraft

Medical Device Biomaterialssigmagraft.com

SigmaGraft Biomaterials is a privately held U.S. manufacturer of dental and orthopedic biomaterials — bone grafts, resorbable membranes, synthetic bioceramics, and wound dressings — sold in more than 60 countries to clinicians through distribution, e-commerce, and contract manufacturing.

What SigmaGraft does

SigmaGraft Biomaterials, Inc. is a privately held U.S. manufacturer of dental and orthopedic biomaterials, founded in 2010 and operating from Brea, California (corporate headquarters at 450 Apollo St Ste B) and Fullerton, California (manufacturing facility at 575 Sally Place). The company designs, produces, and distributes bone graft substitutes, resorbable collagen membranes, synthetic bioceramics, wound dressings, and sutures used in guided bone regeneration (GBR), guided tissue regeneration (GTR), dental implantology, periodontal surgery, spinal fusion, and orthopedic trauma. Its portfolio spans allograft (SigmaOss), xenograft (InterOss), bone-collagen composites (InterOss Collagen), biphasic and tricalcium phosphate ceramics (BoneSigma BCP/TCP), resorbable collagen membranes (InterCollagen Guide), DBM products (AlloGen), active bone graft substitutes for spine (ExcellBone Active), sports medicine/trauma grafts (MaximOss), and wound dressings (SigmaPlug, SigmaTape).

Underlying technology centers on biomaterial scaffolds with controlled porous architecture (e.g., InterOss macropores of 40–60 μm and micro-channels ≤1.5 μm) designed to mimic natural trabecular bone and support osteoconduction. Manufacturing is vertically integrated in ISO Class 7 cleanroom environments under ISO 13485 certification, enabling both proprietary product lines and contract manufacturing services for other medical device companies.

SigmaGraft monetizes through one-time product sales across three channels: a direct e-commerce storefront (shop.sigmagraft.com), a dedicated customer service sales team, and a global distribution network serving more than 60 countries. The company also offers contract manufacturing for third-party dental, spine, and orthopedic device companies. Customer education and clinical faculty relationships (e.g., SigmaGraft Bone & Tissue Regeneration CE course, VISTA Institute programs) function as a marketing and brand-building layer rather than a direct revenue stream. Pricing is quote-based and not publicly disclosed; no revenue figures, funding rounds, or ownership disclosures are available in the source data, indicating an independent, likely founder-controlled private company.

SigmaGraft firmographics

Firmographics
Name
SigmaGraft
Legal name
SigmaGraft Biomaterials, Inc.
Website
https://sigmagraft.com
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
11–50 employees
Short description
SigmaGraft Biomaterials is a privately held U.S. manufacturer of dental and orthopedic biomaterials — bone grafts, resorbable membranes, synthetic bioceramics, and wound dressings — sold in more than 60 countries to clinicians through distribution, e-commerce, and contract manufacturing.
Ownership category
akta.pro rank

SigmaGraft industry classification

Industry
Product category
Medical Device Biomaterials
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Dental Equipment and Supplies Manufacturing (339114), Biological Product (except Diagnostic) Manufacturing (325414), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (42345)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Biological Products, (No Disgnostic Substances) (2836), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
akta.pro primary industry
Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM) (HLAHAEAG)
akta.pro secondary industries
Cartilage, Bone & Musculoskeletal Regeneration (HLAAAGAH), Tissue-Engineered Constructs & Scaffolds (natural/synthetic biomaterials) (HLAAAGAB), Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts) (HLAHALAE), Implant Prosthetics & Abutment Fabrication (HLABAJAC)

Keywords

  • Bone graft substitutes
  • Dental biomaterials
  • Orthopedic regenerative products
  • Resorbable collagen membranes
  • Synthetic bioceramics

Where SigmaGraft is headquartered

Location

Headquarters

HQ city
Fullerton
HQ country
United States
HQ region
North America

Offices2 records

Markets served

SigmaGraft business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Biomaterial Products: Sale of bone graft substitutes, collagen membranes, wound dressings, and related medical devices for dental and orthopedic applications. Products are sold directly through e-commerce and distribution network.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goMedical device biomaterial products - pricing available upon request

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

SigmaGraft product offering

Product offering

Core offering

SigmaGraft manufactures and sells biomaterial products for bone and tissue regeneration, including allograft and xenograft bone substitutes, bone-collagen composites, synthetic biphasic and tricalcium phosphate bioceramics, resorbable collagen membranes, wound dressings, and surgical sutures. These products are used by dental professionals and orthopedic surgeons for guided bone regeneration, ridge preservation, dental implant placement, sinus augmentation, periodontal defect treatment, spinal fusion, trauma surgery, and sports medicine. The company also offers contract manufacturing services to other medical device companies using its ISO Class 7 facilities.

Product overview

SigmaGraft Biomaterials is a manufacturer of biomaterials for dental and orthopedic surgeries specializing in bone and tissue regeneration products. The product portfolio includes allograft bone substitutes (SigmaOss™), xenograft bone grafts (InterOss®), bone-collagen composites, biphasic and tricalcium phosphate ceramics (BoneSigma™), resorbable collagen membranes (InterCollagen® Guide), wound dressings (SigmaPlug™, SigmaTape™), demineralized bone matrix (AlloGen™ DBM), and sutures. The company operates in dental (bone grafting, tissue regeneration, wound care) and orthopedic (spine, sports medicine/trauma) segments, selling products in over 60 countries worldwide.

Differentiator

Problem solved

Functional benefit

Brands

  • InterOss: Anorganic cancellous bone graft granules derived from bovine source, featuring naturally interconnected porous architecture for osteoconductive scaffold in guided bone regeneration.
  • InterOss Collagen
  • InterCollagen Guide
  • SigmaOss
  • BoneSigma
  • AlloGen
  • ExcellBone Active
  • SigmaPlug
  • SigmaTape

Products and services

  • SigmaOss™

Quantifiable outcome

  • Products registered and sold in more than 60 countries worldwide

Companies that use SigmaGraft

Customer profile

Named customers8 records

Segments3 records

Ideal customer profiles3 records

SigmaGraft technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

SigmaGraft partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • Leading Universities (Research Collaborations)coreStrategic or Co-development PartnerSigmaGraft has established close partnerships with several leading universities for research and development. These collaborations provide access to cutting-edge research and technology, allowing the company to work alongside leading minds in the biomaterials field. Research has been published in several renowned, prestigious journals.
  • VISTA InstitutecoreStrategic or Co-development PartnerSigmaGraft partners with VISTA Institute for dental education programs. Joint program on Management of Implant Functional and Esthetic Complications scheduled for July 11-12, 2026 in Woodland Hills, CA, featuring multiple clinicians and offering 16 CE units.
  • EAO (European Association for Osseointegration)minorGTM or Marketing PartnerSigmaGraft Industry Forums at EAO Congress 2026 in Lisbon, Portugal featuring Dr. Hom-Lay Wang discussing advancements in bone regeneration and implant therapy.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

SigmaGraft competitors and assessment

Company assessment

Broad incumbents

  • Stryker: Stryker's orthobiologics portfolio includes Vitoss synthetic bone graft, OP-1 putty, and various allograft products. Comparable as a broad incumbent selling bone graft substitutes into orthopedic, spine, and trauma channels overlapping with SigmaGraft's orthopedic segment.
  • Medtronic (Spine & Biologics): Through its Spine & Biologics division, Medtronic offers Infuse (rhBMP-2), Grafton DBM, and Mastergraft synthetic bone grafts. Directly comparable in orthopedic spine and trauma bone graft substitutes where SigmaGraft's AlloGen DBM and BoneSigma TCP compete.
  • Zimmer Biomet: Major orthopedic and dental medical device company offering RegenerOss bone graft substitutes and dental implant solutions. Comparable because it sells allograft, xenograft, and synthetic bone grafts into the same dental and orthopedic surgical call points.
  • Dentsply Sirona: Global dental equipment and consumables leader with bone graft substitute offerings (e.g., Symbios) and the largest installed base in dental practices. Comparable as a broad incumbent in the dental regenerative materials space.

Direct peers

  • NovaBone Products: Specialist manufacturer of synthetic bioactive glass and calcium phosphate bone graft substitutes (NovaBone IRM, NovaBone Morsels). Direct peer for SigmaGraft's BoneSigma BCP/TCP ceramic lines in dental and orthopedic bone regeneration.
  • Geistlich Pharma: The global leader in dental bone regeneration (Bio-Oss xenograft, Bio-Gide membrane). Direct peer with overlapping product portfolio in dental bone graft substitutes and resorbable collagen membranes serving periodontists, oral surgeons, and implantologists worldwide.
  • Biomatlante: French specialist in synthetic bone graft substitutes (MBCP biphasic calcium phosphate). Direct peer for SigmaGraft's bioceramic bone substitutes with comparable technology positioning in dental and orthopedic bone regeneration.
  • BioHorizons (Henry Schein): Dental implant company with a regeneration portfolio including MinerOss xenograft and allograft bone substitutes plus resorbable membranes. Direct peer in dental bone grafting and tissue regeneration products sold through the same implantology channel.
  • ACE Surgical Supply: US-based dental surgical supply company offering bone graft materials, membranes, and regenerative products to periodontists and oral surgeons. Comparable mid-size peer with overlapping dental bone graft and tissue regeneration catalog.

Emerging players

  • Collagen Matrix / Collagen Solutions: Specialist manufacturer of collagen-based medical devices including dental membranes and bone graft substitutes. Comparable as a focused player in the collagen/membrane niche where SigmaGraft's InterCollagen Guide competes.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

SigmaGraft social profiles

Digital presence

SigmaGraft compliance and trust

Trust signal

Compliance1 record

SigmaGraft financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SigmaGraft leadership team

Management profile

Number of profiles

SigmaGraft funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SigmaGraft M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SigmaGraft

What does SigmaGraft do?

SigmaGraft manufactures and sells biomaterial products for bone and tissue regeneration, including allograft and xenograft bone substitutes, bone-collagen composites, synthetic biphasic and tricalcium phosphate bioceramics, resorbable collagen membranes, wound dressings, and surgical sutures. These products are used by dental professionals and orthopedic surgeons for guided bone regeneration, ridge preservation, dental implant placement, sinus augmentation, periodontal defect treatment, spinal fusion, trauma surgery, and sports medicine. The company also offers contract manufacturing services to other medical device companies using its ISO Class 7 facilities.

Is SigmaGraft a public or private company?

SigmaGraft is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was SigmaGraft founded?

SigmaGraft was founded in 2010. It employs 11 to 50 people.

Where is SigmaGraft based?

SigmaGraft is headquartered in Fullerton, United States, in the North America region.

How does SigmaGraft make money?

One revenue line is on record: biomaterial Products.

Who are SigmaGraft's main competitors?

Broad incumbents on record are Stryker, Medtronic (Spine & Biologics), Zimmer Biomet and Dentsply Sirona. Direct peers are NovaBone Products, Geistlich Pharma, Biomatlante, BioHorizons (Henry Schein) and ACE Surgical Supply. Collagen Matrix / Collagen Solutions is listed as an emerging player.

Does SigmaGraft have an API?

No public API is recorded for SigmaGraft.

What industry is SigmaGraft in?

SigmaGraft's product category is Medical Device Biomaterials. Its primary akta.pro industry code is HLAHAEAG, Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM), with a secondary code of HLAAAGAH, Cartilage, Bone & Musculoskeletal Regeneration. Its NAICS code is 339113 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals